LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced that it has been selected...
Target for completing enrollment of the chronic cohort in the Phase 1b/2a clinical trial moved to Q3 2024Subacute cohort protocol...
Endobits Automated Remote Patient Management Platform Will Now Deploy Its Industry-Leading AI-Powered Software to Securely Integrate Dexcom CGM Data VANCOUVER,...
VANCOUVER, BC / ACCESSWIRE / May 16, 2024 / Frequency Exchange Corp. ("Frequency Exchange" or the "Company") (TSXV:FREQ) is excited...
TORONTO, ON / ACCESSWIRE / May 16, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), provides an update by way...
Enrollment completed in potentially pivotal GBM study evaluating Berubicin; Topline data expected in first half of 2025Company committed to addressing...
CHAMERSTRASSE, SWITZERLAND / ACCESSWIRE / May 16, 2024 / In the ever-evolving world of cannabis and CBD, where products are...
The Glinka family invested $4.5 million into Nutriband through the Company's April 2024 private placementORLANDO, FL / ACCESSWIRE / May...
Toronto, Ontario--(Newsfile Corp. - May 16, 2024) - Celly Nutrition Corp, makers of unbuzzd™, a pioneering beverage company for innovative,...
Nanotechnology testing results will provide insights to continue to move towards large scale commercial productionOakville, Ontario--(Newsfile Corp. - May 16,...
NEW YORK--(BUSINESS WIRE)--Accenture (NYSE: ACN) has made a strategic investment, through Accenture Ventures, in Turbine, a predictive simulation company that...
LUND, SE / ACCESSWIRE / May 16, 2024 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F)Spago Nanomedical's annual report for 2023 is from today...
INDEPENDENT STUDY OF OVARIAN CANCER CTCS HARVESTED BY THE PARSORTIX SYSTEM HIGHLIGHTS POTENTIAL TO PREDICT PROGRESSION FREE SURVIVAL FOR DRUG...
Mr. Smith brings 20 years of successful leadership experience in Sales, Commercial Operations, and Customer SuccessSAN FRANCISCO--(BUSINESS WIRE)--Element Science, an...
HOLLYWOOD, FL / ACCESSWIRE / May 15, 2024 / The TAR Network is excited to announce the upcoming SCARS to...
DURHAM, NC / ACCESSWIRE / May 15, 2024 / The Glioblastoma Foundation announced today the establishment of a pioneering Genomic...
Conference call begins at 10:00 a.m. Eastern time on Thursday, May 16, 2024 WOBURN, MA / ACCESSWIRE / May 15,...
Q3 2024 ADHD Portfolio net revenue up 49% compared to Q3 2023Q3 2024 adjusted EBITDA 1 improved by $7.0 million...
Expects Revenue for Full Year 2024 of $116 Million to $120 MillionBELGRADE, MT / ACCESSWIRE / May 15, 2024 /...
- DMT310 Phase 3 Spongilla Treatment of Acne Research (STAR-1) clinical trial enrollment remains on track -- Dermata continues discussions...